Drugs News and Research

RSS

Study identifies new biomarker for depression in diabetes

A study published in the current issue of Psychotherapy and Psychosomatic has identified a biomarker for depression in diabetes. Findings of epidemiological studies have shown an overall 2-fold increased prevalence of depression in patients with type 2 diabetes compared with the general population worldwide.

16 Oct 2017

FDA clears new Senhance System that can help facilitate minimally invasive surgery

Today, the U.S. Food and Drug Administration cleared the Senhance System, a new robotically-assisted surgical device that can help facilitate minimally invasive surgery.

16 Oct 2017

Investigating new cancer therapy candidates with live-cell imaging

There are two main things that we've worked on in the lab as regards to drug studies. One is identifying new combinations of drugs, and working on why a combination of drugs should work better than each alone.

From Sartorius 16 Oct 2017

First 7T MRI system receives FDA clearance for clinical use in the United States

Today, the U.S. Food and Drug Administration cleared the first seven tesla (7T) magnetic resonance imaging (MRI) device, more than doubling the static magnetic field strength available for use in the United States.

16 Oct 2017

Scientists validate biomarker indicative of brain cancer patient's prognosis and drug response

Scientists at the Icahn School of Medicine at Mount Sinai, Sema4, and collaborating institutions including Colorado State University and Fred Hutchinson Cancer Center reported results today from a glioblastoma study in which they validated a biomarker indicative of a patient's prognosis and likely response to specific therapies.

16 Oct 2017

Researchers identify several previously unknown antibiotic resistance genes

Researchers at Chalmers University of Technology and the University of Gothenburg, Sweden, have found several previously unknown genes that make bacteria resistant to last-resort antibiotics.

16 Oct 2017

TSRI scientists develop molecular model for improving design of osteoporosis treatments

Using advanced mass spectrometry technology, scientists from the Florida campus of The Scripps Research Institute have developed a molecular model that may provide a new framework for improving the design of osteoporosis treatments.

13 Oct 2017

New study describes unique role of androgens in kidney cancer

A new study is believed to be the first to describe the unique role of androgens in kidney cancer, and it suggests that a new approach to treatment, targeting the androgen receptor (AR), is worth further investigation.

13 Oct 2017

New study uncovers 13 previously-unknown genetic risk variants for restless legs syndrome

A new study into the genetics underlying restless legs syndrome has identified 13 previously-unknown genetic risk variants, while helping inform potential new treatment options for the condition.

13 Oct 2017

MD Anderson researchers chosen for national effort to expand reach of cancer immunotherapy

A major national effort to expand the reach of cancer immunotherapy to benefit more patients will draw upon the expertise of a team of researchers at The University of Texas MD Anderson Cancer Center.

13 Oct 2017

Fever in first trimester of pregnancy increases risk for birth defects, study shows

Fevers in a mother's first trimester of pregnancy increase the baby's risk for some heart defects and facial deformities such as cleft lip or palate, but exactly how this happens is unclear. Scientists have debated whether a virus or other infection causes the defects, or if fever alone is the problem.

12 Oct 2017

USC discovery may one day lead to new therapies for liver cancer

A Keck School of Medicine of USC research team has identified how cancer stem cells survive. This finding may one day lead to new therapies for liver cancer, one of the few cancers in the United States with an incidence rate that continues to balloon.

12 Oct 2017

Salk scientists receive $2.5 million funding to conduct pancreatic cancer clinical study

Salk Professor and HHMI Investigator Ronald Evans has been awarded $2.5 million by Stand Up 2 Cancer (SU2C) as part of a multi-institution team to conduct clinical studies to open up a new avenue for immunotherapy in the treatment of pancreatic cancer.

12 Oct 2017

Researchers to explore effects of maternal nitrate consumption on birth outcomes

Nitrate is the most common contaminant in aquifers and tap water throughout the world, but its effects on human health remain largely unknown.

12 Oct 2017

Anthem eases up on premium hikes after state scrutiny

Insurance giant Anthem Blue Cross agreed to reduce two planned premium increases for 2018 after California regulators questioned the company's rationale for raising rates by as much as it had initially proposed.

12 Oct 2017

Cholesterol byproduct acts on specific immune cells to facilitate breast cancer spread

High cholesterol levels have been associated with breast cancer spreading to other sites in the body, but doctors and researchers don't know the cause for the link.

12 Oct 2017

Study documents gene mutation as cause of cancer form in the liver

There is no effective treatment for the cancer form found in the liver called fibrolamellar hepatocellular carcinoma, which is mainly found among children and young people.

12 Oct 2017

Researchers uncover enzyme behind immune cell response

Monash University researchers have revealed the role played by an enzyme that is pivotal to the process of clearing infection in the body.

12 Oct 2017

TSRI scientists demonstrate repurposing of DNA to create new substances

DNA evolved to store genetic information, but in principle this special, chain-like molecule can also be adapted to make new materials. Chemists at The Scripps Research Institute have now published an important demonstration of this repurposing of DNA to create new substances with possible medical applications.

12 Oct 2017

Existing drugs could help patients with rare form of bone cancer

Patients with a rare bone cancer of the skull and spine - chordoma - could be helped by existing drugs, suggest scientists from the Wellcome Trust Sanger Institute, University College London Cancer Institute and the Royal National Orthopaedic Hospital NHS Trust.

12 Oct 2017

Drugs News and Research

Study identifies new biomarker for depression in diabetes

FDA clears new Senhance System that can help facilitate minimally invasive surgery

Investigating new cancer therapy candidates with live-cell imaging

First 7T MRI system receives FDA clearance for clinical use in the United States

Scientists validate biomarker indicative of brain cancer patient's prognosis and drug response

Researchers identify several previously unknown antibiotic resistance genes

TSRI scientists develop molecular model for improving design of osteoporosis treatments

New study describes unique role of androgens in kidney cancer

New study uncovers 13 previously-unknown genetic risk variants for restless legs syndrome

MD Anderson researchers chosen for national effort to expand reach of cancer immunotherapy

Fever in first trimester of pregnancy increases risk for birth defects, study shows

USC discovery may one day lead to new therapies for liver cancer

Salk scientists receive $2.5 million funding to conduct pancreatic cancer clinical study

Researchers to explore effects of maternal nitrate consumption on birth outcomes

Anthem eases up on premium hikes after state scrutiny

Cholesterol byproduct acts on specific immune cells to facilitate breast cancer spread

Study documents gene mutation as cause of cancer form in the liver

Researchers uncover enzyme behind immune cell response

TSRI scientists demonstrate repurposing of DNA to create new substances

Existing drugs could help patients with rare form of bone cancer

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News